The acquisition quote for Bausch ’s is expected to be between 13 billion US dollars and 14 billion US dollars, or $25 per share. The formal acquisition quote is expected to be announced at the end of this month.
Zhixiang Finance APP learned that, according to insiders, private equity firms TPG (TPG.US) and Blackstone (BX.US) are jointly bidding for Bausch lens (BLCO.US). As of the publication, the stock rose 11.86% before the market opened, to $21.78.
The expected acquisition quote for Bausch Lomb is 13 to 14 billion US dollars, or $25 per share. The formal acquisition quote is expected to be announced by the end of this month.
Other private equity firms considering submitting quotes have all withdrawn. As early as September, sources familiar with the matter said that private equity firms including Blackstone Group, Advent International, TPG Capital, CVC Capital, and Hellman & Friedman were evaluating a potential acquisition offer for Bausch Health.
The eye care company is considering a sale to address concerns raised by Apollo Global Management and other lending institutions about its plan to separate from its parent company, Bausch Health. Due to the impact on the parent company's balance sheet, Apollo has expressed concerns about the divestiture plan.
